Literature DB >> 21880841

Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions.

Shigeo Nagashima1, Masaharu Takahashi1, Suljid Jirintai1, Toshinori Tanaka1, Tsutomu Nishizawa1, Jiro Yasuda2, Hiroaki Okamoto1.   

Abstract

We have previously demonstrated that an intact PSAP motif in the ORF3 protein is required for the formation and release of membrane-associated hepatitis E virus (HEV) particles with ORF3 proteins on their surface. In this study, we investigated the direct interaction between the ORF3 protein and tumour susceptibility gene 101 (Tsg101), a cellular factor involved in the budding of viruses containing the P(T/S)AP late-domain, in PLC/PRF/5 cells expressing the wild-type or PSAP-mutated ORF3 protein and Tsg101 by co-immunoprecipitation. Tsg101 bound to wild-type ORF3 protein, but not to the PSAP-inactive ORF3 protein. To examine whether HEV utilizes the multivesicular body (MVB) pathway to release the virus particles, we analysed the efficiency of virion release from cells upon introduction of small interfering RNA (siRNA) against Tsg101 or dominant-negative (DN) mutants of Vps4 (Vps4A and Vps4B). The relative levels of virus particles released from cells depleted of Tsg101 decreased to 6.4 % of those transfected with negative control siRNA. Similarly, virion egress was significantly reduced by the overexpression of DN forms (Vps4AEQ or Vps4BEQ). The relative levels of virus particles released from cells expressing Vps4AEQ and Vps4BEQ were 19.2 and 15.6 %, respectively, while the overexpression of wild-type Vps4A and Vps4B did not alter the levels of virus release. These results indicate that the ORF3 protein interacts with Tsg101 through the PSAP motifs in infected cells, and that Tsg101 and the enzymic activities of Vps4A and Vps4B are involved in HEV release, thus suggesting that HEV requires the MVB pathway for egress of virus particles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880841     DOI: 10.1099/vir.0.035378-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  41 in total

1.  Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.

Authors:  Saumya Anang; Nidhi Kaushik; Smita Hingane; Anita Kumari; Jyoti Gupta; Shailendra Asthana; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

2.  The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release.

Authors:  Scott P Kenney; R S Pudupakam; Yao-Wei Huang; F William Pierson; Tanya LeRoith; Xiang-Jin Meng
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  Molecular cloning, expression and characterization of a novel vacuolar protein sorting 4 gene in silkworm, Bombyx mori.

Authors:  Hengchuan Xia; Chunxia Zhang; Fan Feng; Yi Yuan; Yang Zhou; Xiaoyong Liu; Keming Zhu; Qin Yao; Keping Chen
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

4.  Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.

Authors:  Nicolas Capelli; Olivier Marion; Martine Dubois; Sophie Allart; Justine Bertrand-Michel; Sébastien Lhomme; Florence Abravanel; Jacques Izopet; Sabine Chapuy-Regaud
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.

Authors:  Shigeo Nagashima; Masaharu Takahashi; Tominari Kobayashi; Tsutomu Nishizawa; Takashi Nishiyama; Putu Prathiwi Primadharsini; Hiroaki Okamoto
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 6.  Therapeutic targets for the treatment of hepatitis E virus infection.

Authors:  Scott P Kenney; Xiang-Jin Meng
Journal:  Expert Opin Ther Targets       Date:  2015-06-13       Impact factor: 6.902

7.  Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses.

Authors:  Xin Yin; Charuta Ambardekar; Yurong Lu; Zongdi Feng
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 8.  Virus spread in the liver: mechanisms, commonalities, and unanswered questions.

Authors:  Alexi Tallan; Zongdi Feng
Journal:  Future Virol       Date:  2020-10-27       Impact factor: 1.831

9.  A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.

Authors:  Min Zhao; Xiao-Jing Li; Zi-Min Tang; Fan Yang; Si-Ling Wang; Wei Cai; Ke Zhang; Ning-Shao Xia; Zi-Zheng Zheng
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

10.  Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Trends Microbiol       Date:  2013-11-19       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.